DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ragni MV, Malec LM.
Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance.
Expert Rev Hematol 2014;
7 (6) 747-755
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.